พบ "Public health policy"ทั้งหมด 1,226 ผลลัพธ์
Evidence-informed policy formulation the case of the voucher scheme for maternal and child health in Myanmar (2014)
Yot Teerawattananon,1 Sripen Tantivess,1 Pitsaphun Werayingyong,1
Pritaporn Kingkaew,1 Nilar Tin,2 San San Aye,3 Phone Myint3
Abstract
Introduction: In 2010, with financial support from the Global Alliance for Vaccine and Immunization’s Health System Strengthening programme, the Government of
Evidence-based decision-making in Asia-Pacific with rapidly changing health-care systems: Thailand, South Korea, and Taiwan. (2009)
Evidence-Based Decision-Making in Asia-Pacific with Rapidly Changing Health-Care Systems: Thailand, South Korea, and Taiwan.
Thidaporn Jirawattanapisal1 Pritaporn Kingkaew2 Tae-Jin Lee3 Ming-Chin Yang4
1International Health Policy Program, Ministry of Public Health, Muang Nonthaburi,Thailand;
2
Evaluating the Value for Money of Precision Medicine from Early Cycle to Market Access: A Comprehensive Review of Approaches and Challenges
Generic reference cases for economic evaluation (EE) of “cure-based” health technologies may not fit into the new healthcare paradigm of precision medicine (PM). Current EE approaches were challenged by the complex evolving decision space of PM, lack of clinical evidence due to small patient cluster
EU agency lifts lid on drug data secrets
(Reuters) – Europe’s medicines regulator, criticised in the past for excessive secrecy, is opening its data vaults to systematic scrutiny in a move that will let independent researchers trawl through millions of pages of clinical trial information.The change is a landmark in transparency that puts E
Estimating the willingness to pay for a quality-adjusted life year in Thailand: does the context of health gain matter? (2013)
Estimating the willingness to pay for a quality-adjusted life year in Thailand: does the context of health gain matter?
Thavorncharoensap M1, Teerawattananon Y, Natanant S, Kulpeng W, Yothasamut J, Werayingyong P
1Department of Pharmacy, Faculty of Pharmacy, Mahidol University, Thailand ; Heal
Estimating the shares of the value of branded pharmaceuticals accruing to manufacturers and to patients in the Thai healthcare system
The Thai healthcare system faces pressure to fund high-cost new branded pharmaceuticals. Paying more may encourage innovation with positive implications for future population health, but it also means less money is available to fund other healthcare with negative implications for current population
Estimating the potential overdiagnosis and overtreatment of acute appendicitis in Thailand using a secondary data analysis of service utilization before, during and after the COVID-19 lockdown policy
Acute appendicitis is one of the most common surgical emergencies; however, optimal diagnosis and treatment of acute appendicitis remains challenging. We used the coronavirus disease 2019 (COVID-19) lockdown policy as a natural experiment to explore potential overdiagnosis and overtreatment of acute
10 / หน้า